Pharmaceuticals, Biotechnology and Life Sciences
Vectura Group is moving on with researching and testing its VR647, a drug/device combination to treat asthma in children for the US market.
A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.
After Bristol-Myers Squibb (Bristol) said on Friday that it won’t ask FDA for faster approval of Opdivo/Yervoy combination for lung cancer, it agreed today with Ono Pharmaceutical to settle all patent-infringement charges related to Merck’s PD-1 antibody Keytruda.
Ethicon Endo-Surgery has bought a private medical device company Megadyne Medical Products, Inc. for an unknown price.
Flu, or influenza, is a very contagious, acute, viral respiratory infection. Influenza viruses vary in a high degree. The extent…
Bristol-Myers Squibb said on Thursday that it won’t seek an accelerated approval for the combination of Opdivo plus Yervoy in first-line lung cancer in the U.S.
Abzena has made a deal with a San Diego-based biopharmaceutical company for Abzena’s novel site–specific ThioBridge antibody drug conjugate (ADC) linker technology, which links antibodies and other proteins to drugs. The $300 million worth agreement with the…
U.S. Food and Drug Administration (FDA) has approved Allergan’s Rhofade skin desease cream, a topical treatment of persistent facial erythema (redness)…
Anavex has ensured most of the cash for a U.S. multicentre Phase 2 clinical trial of Rett syndrome treatment Anavex2-73.
Horizon Pharmaceuticals has warned by the Food and Drug Administration (FDA) to better respond on resolving certain issues it had in its drug manufacturing facilities, that the FDA pointed out after an inspection in 2015.